[Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
D000109:Acetylcholine / Q000502:physiology; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D001921:Brain / Q000187:drug effects; D004298:Dopamine / Q000502:physiology; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D011954:Receptors, Dopamine / Q000187:drug effects
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D000109:Acetylcholine; D004298:Dopamine
Stato attuale delle conoscenze sugli effetti collaterali neurotropi dei farmaci neurolettici.